Department of Nephrology, St. Bortolo Hospital, Vicenza, Italy.
Blood Purif. 2010;30(3):214-20. doi: 10.1159/000320126. Epub 2010 Oct 14.
Several aspects of acute kidney injury (AKI) management, including medical approaches to AKI patients and the optimal form of renal replacement therapy (RRT), remain a matter of debate.
The responses of 440 participants to a questionnaire on several points of AKI management, submitted during the 4th International Course on Critical Care Nephrology in June 2007, were analyzed.
The most common answer to the definition of AKI was the use of the RIFLE criteria (55%), followed by the presence of oligoanuria (24%). Responders seemed to preferentially start dialysis within a creatinine range from 2.3-3.4 mg/dl (28%) to 3.4-4.5 mg/dl (26%) and with a urine output level of 150-200 ml/12 h (43%). About 30% of responders showed that they would prescribe dialysis only in case of severe fluid overload (requiring mechanical ventilation and/or causing impaired skin integrity). Continuous RRT is used by most specialists (86%), followed by intermittent hemodialysis (65%), sustained low-efficiency dialysis (28%) and peritoneal dialysis (30%). The preferred RRT dosage was '35 ml/kg/h' (46%) but 37% of responders did not explicitly answer this critical question. Bleeding, hypotension, filter clotting, vascular access and sepsis treatment were the most frequent complications and concerns of RRT.
New classifications such as the RIFLE criteria did improve the well-known uncertainty about the definition of AKI. Awareness of the prescription and standardization of an adequate treatment dose seemed to have increased in recent years, even if there is still a significant level of uncertainty on this specific issue. Several concerns and RRT complications, such as bleeding and anticoagulation strategies, still need further exploration and development.
急性肾损伤(AKI)的几个治疗方面,包括 AKI 患者的治疗方法和最佳肾脏替代疗法(RRT)形式,仍存在争议。
对 2007 年 6 月第四届国际危重病肾脏病学课程期间提交的关于 AKI 管理若干要点的 440 名参与者的问卷回答进行了分析。
AKI 的最常见定义是使用 RIFLE 标准(55%),其次是少尿(24%)。应答者似乎更倾向于在肌酐范围 2.3-3.4 mg/dl(28%)至 3.4-4.5 mg/dl(26%)和尿量 150-200 ml/12 h(43%)开始透析。约 30%的应答者表示,他们仅在出现严重液体超负荷(需要机械通气和/或导致皮肤完整性受损)的情况下才会进行透析。大多数专家使用连续性 RRT(86%),其次是间歇性血液透析(65%)、持续低效透析(28%)和腹膜透析(30%)。首选的 RRT 剂量为“35 ml/kg/h”(46%),但 37%的应答者没有明确回答这个关键问题。出血、低血压、滤器堵塞、血管通路和脓毒症治疗是 RRT 最常见的并发症和关注问题。
新的分类标准,如 RIFLE 标准,确实提高了 AKI 定义的已知不确定性。近年来,人们对处方和标准化治疗剂量的认识似乎有所提高,尽管在这一具体问题上仍存在很大的不确定性。一些关注问题和 RRT 并发症,如出血和抗凝策略,仍需要进一步探讨和发展。